Acadia Healthcare's Q3 Performance and Growth Strategies
Acadia Healthcare (Nasdaq: ACHC) reported strong third-quarter results with $895.3 million in total revenue, a 5.1% increase from the same period in 2025. The company has been focused on expanding its bed capacity through new facilities and acquisitions.
Bed Expansion and Project Updates
- Q3 Additions: During Q3, Acadia added 220 licensed beds from a 144-bed de novo project in Florida and 76 beds at existing facilities.
- Yearly Goal: Throughout 2026, Acadia has opened a total of 542 beds, on track to meet its annual goal of 550 new beds, despite 289 net additions due to bed closures in some facilities.
- Future Projections: By the end of 2026, Acadia is projected to have approximately 12,849 beds in operation, an increase of 1,861 since 2022.
David Duckworth, Acadia’s CFO, highlighted the company's growth potential:
"With the 16 new facilities... we have just an incredible runway of growth over the next few years, as implied by the $60 million of incremental EBITDA that we outlined for next year."
Revenue and Earnings Breakdown
Duckworth also shared the following financial insights:
- They've achieved around $15 million of the $200 million in potential long-term earnings from beds added since 2022.
- Additional earnings will be unlocked in 2027 as facilities mature.
- Approximately $60 million in additional improvements are anticipated in 2027.
Rebuilding and Operational Improvements
After a challenging year in 2025 marked by legal issues and financial costs, Acadia has entered a rebuild period under the leadership of CEO Debbie Osteen and CFO David Duckworth.
- Focus Areas: The company has focused on bed ramping and joint venture projects, improving free cash flow by $110 million.
- Q3 Free Cash Flow: The third quarter of 2025 saw negative $63 million in free cash flow, but it improved to $47 million for the same quarter this year.
Service Mix and Growth Areas
Acadia’s service mix has shifted towards acute facilities, leading to a decline in length of stay. Its legacy facilities experienced growth, while the comprehensive treatment center line of business saw a slight revenue decrease in Q3 compared to last year.
Duckworth aims to reduce startup cost losses to $10 million by year-end 2026, down from $45 million.
Outlook for 2027
Despite potential uncertainties related to Medicaid changes, Acadia executives anticipate continued growth and improvements in 2027, supported by reduced capital spending and increased operational efficiency.